Last quarter (Q0 0), Clockchain AG's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Clockchain AG's net income was $―. See Clockchain AG’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Total Revenue	$ ―	$ 0.00	$ 0.00	$ 15.53K	$ 97.00K	$ 24.00K
Cost of Revenue	$ ―	$ ―	$ 0.00	$ 7.50K	$ 1.19K	$ 0.00
Gross Profit	$ ―	$ ―	$ 0.00	$ 8.02K	$ 98.19K	$ 24.00K
Operating Expense	$ ―	$ 165.69K	$ -308.51K	$ 433.19K	$ 55.70K	$ 280.55K
Operating Income	$ ―	$ -165.69K	$ 308.51K	$ -425.17K	$ 42.49K	$ -256.55K
Net Non Operating Interest Income Expense	$ ―	$ -978.36	$ -4.55K	$ -876.16	$ -9.25K	$ -8.14K
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -8.77M	$ 349.72K	$ -426.05K	$ -574.75K	$ -516.68K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -8.77M	$ 347.05K	$ -426.05K	$ -574.75K	$ -516.68K
Basic EPS	$ ―	$ -111.34	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ -111.34	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ 78.75K	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ 78.75K	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ 1.05K	$ 2.09K	$ 5.88K	$ 12.32K	$ ―
Total Expenses	$ ―	$ 165.69K	$ -308.51K	$ 440.69K	$ 54.51K	$ 280.55K
Net Income From Continuing And Discontinued Operation	$ ―	$ -8.77M	$ 347.05K	$ -426.05K	$ -574.75K	$ -516.68K
Normalized Income	$ ―	$ -169.90K	$ 313.17K	$ -426.05K	$ 33.25K	$ -264.69K
Interest Expense	$ ―	$ 412.08	$ 4.17K	$ 876.16	$ 3.85K	$ 9.03K
EBIT	$ ―	$ -8.76M	$ 353.88K	$ -425.17K	$ -570.90K	$ -507.66K
EBITDA	$ ―	$ -8.76M	$ 354.15K	$ -399.86K	$ -570.84K	$ -507.66K

Currency in USD

Clockchain AG Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing